Home
Filing ID: 2330889
PDF: https://cal-access.sos.ca.gov/PDFGen/pdfgen.prg?filingid=2330889&amendid=0
Table: cvr2_registration
filing_id |
| 2330889 |
| 2330889 |
| 2330889 |
amend_id |
| 0 |
| 0 |
| 0 |
line_item |
| 1 |
| 2 |
| 3 |
rec_type |
| CVR2 |
| CVR2 |
| CVR2 |
form_type |
| F603 |
| F603 |
| F603 |
tran_id |
| 1 |
| 2 |
| 3 |
entity_cd |
| EMP |
| AGY |
| FRM |
entity_id |
| 1351454 |
| None |
| F00475 |
enty_naml |
| Alvarez-Sahagun |
| Governor, DGS, CHHSA, DPH, DHCS, DMHC |
| WILKE FLEURY HOFFELT GOULD & BIRNEY, LLP |
enty_namf |
| Patricia |
| None |
| None |
enty_namt |
| Lobbyist |
| None |
| None |
enty_nams |
| None |
| None |
| None |
|
Table: cvr_registration
filing_id |
| 2330889 |
amend_id |
| 0 |
rec_type |
| CVR |
form_type |
| F603 |
sender_id |
| E23058 |
filer_id |
| E23058 |
entity_cd |
| LEM |
filer_naml |
| ASTRAZENECA PHARMACEUTICALS, LP |
filer_namf |
| None |
filer_namt |
| None |
filer_nams |
| None |
report_num |
| 000 |
rpt_date |
| 2018-12-28 00:00:00 |
ls_beg_yr |
| 2019 |
ls_end_yr |
| 2020 |
qual_date |
| 2019-01-01 00:00:00 |
eff_date |
| None |
bus_city |
| WILMINGTON |
bus_st |
| DE |
bus_zip4 |
| 19803 |
bus_phon |
| 3028863369 |
bus_fax |
| None |
bus_email |
| [email protected] |
mail_city |
| VANCOUVER |
mail_st |
| WA |
mail_zip4 |
| 98685 |
mail_phon |
| None |
sig_date |
| 2018-12-28 00:00:00 |
sig_loc |
| None |
sig_naml |
| Alverez-Sahagun |
sig_namf |
| Patricia |
sig_namt |
| None |
sig_nams |
| None |
prn_naml |
| Alverez-Sahagun |
prn_namf |
| Patricia |
prn_namt |
| None |
prn_nams |
| None |
sig_title |
| Director, State Government Affairs |
stmt_firm |
| None |
ind_cb |
| None |
bus_cb |
| X |
trade_cb |
| None |
oth_cb |
| None |
a_b_name |
| None |
a_b_city |
| None |
a_b_st |
| None |
a_b_zip4 |
| None |
descrip_1 |
| None |
descrip_2 |
| Pharmaceutical and biomedical research, development, manufacturing and sales. |
c_less50 |
| None |
c_more50 |
| None |
ind_class |
| HEA |
ind_descr |
| None |
bus_class |
| None |
bus_descr |
| None |
auth_name |
| None |
auth_city |
| None |
auth_st |
| None |
auth_zip4 |
| None |
lobby_int |
| Legislative & regulatory issues relating to pharmaceutical & biomedical research, development, manufacturing, & patient access to medications. |
influen_yn |
| Y |
firm_name |
| None |
newcert_cb |
| None |
rencert_cb |
| None |
complet_dt |
| None |
lby_reg_cb |
| None |
lby_604_cb |
| None |
st_leg_yn |
| None |
st_agency |
| None |
lobby_cb |
| None |
l_firm_cb |
| None |
|
Table: filer_filings
filer_id |
| 1146941 |
filing_id |
| 2330889 |
period_id |
| 236 |
form_id |
| F603 |
filing_sequence |
| 0 |
filing_date |
| 2018-12-28 00:00:00 |
stmnt_type |
| 10001 |
stmnt_status |
| 11003 |
session_id |
| 2019 |
user_id |
| CAFILER |
special_audit |
| 11003 |
fine_audit |
| 11003 |
rpt_start |
| 2018-12-28 00:00:00 |
rpt_end |
| 2018-12-28 00:00:00 |
rpt_date |
| None |
filing_type |
| 22006 |
|
Table: filings
filing_id |
| 2330889 |
filing_type |
| 22001 |
|
Table: hdr
filing_id |
| 2330889 |
amend_id |
| 0 |
rec_type |
| HDR |
ef_type |
| CAL |
state_cd |
| CA |
cal_ver |
| 2.01 |
soft_name |
| CAL-ACCESS OBJECT MODEL |
soft_ver |
| 1.00 |
hdrcomment |
| None |
|